The Column Group (TCG) is a science-driven venture capital firm based in San Francisco, dedicated to advancing scientific innovation in the life sciences sector. Established in 2007, TCG focuses on building early-stage drug discovery companies by partnering with exceptional scientific founders and entrepreneurs. The firm employs a unique edge-to-edge investment model, supporting companies from inception through exit, and has invested in 55 companies, generating $4.0 billion in returns for its partners and portfolio.